Inhibitory effect of the class III antiarrhythmic drug nifekalant on HERG channels: mode of action

Author： Kushida S.   Ogura T.   Komuro I.   Nakaya H.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.457, Iss.1, 2002-12, pp. : 19-27

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel Antiarrhythmic Compounds with Combined Class IB and Class III Mode of Action

By  

Current Medicinal Chemistry, Vol. 11, Iss. 1, 2004-01 ,pp. : 61-69

Bentham Science Publishers

Access to resources Recommend Favorite

Potentially Significant Drug Interactions of Class III Antiarrhythmic Drugs

By Yamreudeewong W.  

Drug Safety, Vol. 26, Iss. 6, 2003-01 ,pp. : 421-438

Adis International

Access to resources Recommend Favorite

Dofetilide: a class III anti-arrhythmic drug for the treatment of atrial fibrillation

By Torp-Pedersen C.   Brendorp B.   Køber L.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 11, 2000-11 ,pp. : 2695-2704

Informa Healthcare

Access to resources Recommend Favorite

Study of Physicochemical Properties and Development of Pharmaceutial Analysis of the New Antiarrhythmic Class III Drug Cardiocyclide

By Grushevskaya L. N.   Avdyunina N. I.   Stepanenko O. B.   Pyatin B. M.   Prokof'eva V. I.   Lezina V. P.  

Pharmaceutical Chemistry Journal, Vol. 37, Iss. 12, 2003-12 ,pp. : 677-680

Springer Publishing Company

Access to resources Recommend Favorite

A Benefit-Risk Assessment of Class III Antiarrhythmic Agents

By Brendorp B.  

Drug Safety, Vol. 25, Iss. 12, 2002-01 ,pp. : 847-865

Adis International

Access to resources Recommend Favorite